MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 116 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q4 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,577,470 | -66.9% | 157,747 | -58.8% | 0.00% | -100.0% |
| Q2 2023 | $4,764,854 | -3.8% | 383,335 | +8.4% | 0.00% | 0.0% |
| Q1 2023 | $4,954,791 | -11.6% | 353,661 | -9.7% | 0.00% | -50.0% |
| Q4 2022 | $5,605,313 | -85.5% | 391,706 | -74.1% | 0.00% | -83.3% |
| Q3 2022 | $38,643,000 | -7.8% | 1,513,641 | +2.6% | 0.01% | -7.7% |
| Q2 2022 | $41,894,000 | -3.3% | 1,474,620 | +20.1% | 0.01% | +18.2% |
| Q1 2022 | $43,304,000 | -22.9% | 1,227,783 | -8.4% | 0.01% | -21.4% |
| Q4 2021 | $56,172,000 | -63.6% | 1,340,634 | -57.4% | 0.01% | -64.1% |
| Q3 2021 | $154,304,000 | -11.7% | 3,143,904 | -24.9% | 0.04% | -9.3% |
| Q2 2021 | $174,695,000 | +21.7% | 4,186,328 | +3.9% | 0.04% | +13.2% |
| Q1 2021 | $143,548,000 | +29.5% | 4,027,738 | +1.9% | 0.04% | +18.8% |
| Q4 2020 | $110,838,000 | – | 3,951,436 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $908,435,000 | 27.70% |
| Pavadi Capital LLC | 145,610 | $6,101,000 | 4.63% |
| Select Equity Group, L.P. | 20,542,503 | $860,731,000 | 2.35% |
| Beck Bode, LLC | 165,937 | $6,953,000 | 1.74% |
| Ownership Capital B.V. | 3,455,256 | $144,775,000 | 1.57% |
| Parkman Healthcare Partners LLC | 98,688 | $4,135,000 | 0.91% |
| MORGENS WATERFALL VINTIADIS & CO INC | 38,000 | $1,592,000 | 0.86% |
| STONE RUN CAPITAL, LLC | 58,785 | $2,474,000 | 0.80% |
| SECTORAL ASSET MANAGEMENT INC | 110,000 | $4,609,000 | 0.69% |
| Connacht Asset Management LP | 16,551 | $693,000 | 0.68% |